[go: up one dir, main page]

AU3515597A - Inhibition of antigen-specific ige production by antigen coupled to membrane igepetide - Google Patents

Inhibition of antigen-specific ige production by antigen coupled to membrane igepetide

Info

Publication number
AU3515597A
AU3515597A AU35155/97A AU3515597A AU3515597A AU 3515597 A AU3515597 A AU 3515597A AU 35155/97 A AU35155/97 A AU 35155/97A AU 3515597 A AU3515597 A AU 3515597A AU 3515597 A AU3515597 A AU 3515597A
Authority
AU
Australia
Prior art keywords
antigen
igepetide
inhibition
membrane
specific ige
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35155/97A
Inventor
Tse Wen Chang
Alex Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanox Inc
Original Assignee
Tanox Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanox Biosystems Inc filed Critical Tanox Biosystems Inc
Publication of AU3515597A publication Critical patent/AU3515597A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52Constant or Fc region; Isotype

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
AU35155/97A 1997-05-30 1997-05-30 Inhibition of antigen-specific ige production by antigen coupled to membrane igepetide Abandoned AU3515597A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1997/011707 WO1998053843A1 (en) 1997-05-30 1997-05-30 INHIBITION OF ANTIGEN-SPECIFIC IgE PRODUCTION BY ANTIGEN COUPLED TO MEMBRANE IgE PETIDE

Publications (1)

Publication Number Publication Date
AU3515597A true AU3515597A (en) 1998-12-30

Family

ID=22261213

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35155/97A Abandoned AU3515597A (en) 1997-05-30 1997-05-30 Inhibition of antigen-specific ige production by antigen coupled to membrane igepetide

Country Status (2)

Country Link
AU (1) AU3515597A (en)
WO (1) WO1998053843A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060052592A1 (en) 2002-06-20 2006-03-09 Levinson Arnold I Vaccines for suppressing ige-mediated allergic disease and methods for using the same
EP1941275B1 (en) * 2005-09-29 2013-07-24 Medimmune, Inc. Method of identifying membrane lg specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells
EP1972640A1 (en) * 2007-03-23 2008-09-24 Biomay AG Apoptosis inducing antibodies
EP2401300B1 (en) 2009-02-25 2018-01-10 Academia Sinica ANTI-C[epsilon]mX ANTIBODIES CAPABLE OF BINDING TO HUMAN mIgE ON B LYMPHOCYTES
EP2838919A4 (en) 2012-04-20 2016-03-23 Academia Sinica ANTI-MIGE ANTIBODIES (MEMBRANE-RELATED IGE) THAT CONNECT TO THE JUNCTION BETWEEN THE CH4 AND C EPSILON MX DOMAINS
CA2991544A1 (en) 2015-07-07 2017-01-12 Affiris Ag Vaccines for the treatment and prevention of ige mediated diseases
CN111741768B (en) 2017-10-31 2024-12-27 合一生技股份有限公司 Treatment of IgE-mediated allergic diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254671A (en) * 1990-04-27 1993-10-19 Tanox Biosystems, Inc. Extracellular segments of human e immunoglobulin anchoring peptides and antibodies specific therefor
US5274075A (en) * 1987-12-31 1993-12-28 Tanox Biosystems, Inc. Newly identified human epsilon immunoglobulin peptides and related products
US5281699A (en) * 1990-06-01 1994-01-25 Tanox Biosystems, Inc. Treating B cell lymphoma or leukemia by targeting specific epitopes on B cell bound immunoglobulins

Also Published As

Publication number Publication date
WO1998053843A1 (en) 1998-12-03

Similar Documents

Publication Publication Date Title
AU5798596A (en) Production of levulinic acid from carbohydrate-containing ma terials
AU6088896A (en) Production of partially metallised grating structures
AU7172698A (en) Fast-dissolving tablets and methods of their manufacture by direct compression
AUPN967396A0 (en) Improvements relating to plant propagation
AU9450098A (en) Production of esters
AU7473496A (en) Commercial production of avidin in plants
AU1870599A (en) Production of hydrolysate
AU3515597A (en) Inhibition of antigen-specific ige production by antigen coupled to membrane igepetide
AU6373698A (en) Production of L(+)-Lactate
AU7312196A (en) Synthesis of polymerisable phosphodiesters
AU3504895A (en) Natural gas conversion to higher hydrocarbons
AU1919497A (en) Production of acetic acid from methane
AU8580298A (en) Artificial system for the production of infectious human papillomavirus
AU9397598A (en) Conversion of organosulfur compounds to oxyorganosulfur compounds
AU3348395A (en) Improving the yield of plants
AU5178800A (en) Activation of dendritic cells to enhance immunity
AU5629096A (en) Synthesis of difluoromethane
AU6091496A (en) Antibodies to fas antigen capable of inhibiting apoptosis
AU1720501A (en) Methods of producing novel enzymes
AU8040798A (en) Increased production of proteins by using chaperone-like proteins
AU6560196A (en) Cytohesin-PH peptides that affect the ability of integrins to adhere
AU5312096A (en) Immunoassay using antibodies directed to the reaction product of enzymes used as labels
AU6864696A (en) Method of converting thermal energy to mechanical energy
AU5239896A (en) Conversion of substituted 8-chloroquinolines to substituted 8-hydroxyquinolines
AU9300398A (en) System and method for interfacing sound synthesis to movement

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase